Asclepius Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.25 M
- Company Age 45 Year, 9 Months
- Last Filing with ROC 31 Mar 2006
- Open Charges ₹ 0.72 M
About Asclepius Pharmaceutical
Asclepius Pharmaceutical Pvt Ltd (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 May 1979 and has a history of 45 years and nine months. Its registered office is in Punjab, Punjab.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2006. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.25 M.
The company currently has active open charges totaling ₹0.72 M.
Company Details
-
LocationPunjab, Punjab
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232PB1979PTC003970
-
Company No.
003970
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 May 1979
-
Date of AGM
30 Sep 2006
-
Date of Balance Sheet
31 Mar 2006
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Asclepius Pharmaceutical?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Asclepius Pharmaceutical.
Enhance accessibility to Asclepius Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Asclepius Pharmaceutical?
Unlock access to Asclepius Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.72 M
₹0
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.05 Cr
- Oriental Bank Of Commerce : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Dec 1990 | Oriental Bank Of Commerce | ₹0.02 M | Open |
| 30 Oct 1990 | Oriental Bank Of Commerce | ₹0.25 M | Open |
| 26 Aug 1985 | Punjab National Bank | ₹0.20 M | Open |
| 17 Dec 1982 | Punjab National Bank | ₹0.25 M | Open |
How Many Employees Work at Asclepius Pharmaceutical?
Unlock and access historical data on people associated with Asclepius Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asclepius Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asclepius Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.